Hiroyuki Murai1,12, Masayuki Masuda2,12, Angela Genge3,12, Yessar Hussain4,12, Henry J. Kaminski5,12, M. Isabel Leite6,12, Renato Mantegazza7,12, Kimiaki Utsugisawa8,12, Tuan Vu9,12, Melissa Brock10, Babak Boroojerdi10, Mark Vanderkelen10, Guillemette De La Borderie10, Petra W. Duda10, James F. Howard Jr.11,12 (1.Department of Neurology, International University of Health and Welfare, Japan, 2.1Department of Neurology, Tokyo Medical University, Japan, 3.Clinical Research Unit, The Montreal Neurological Institute, Canada, 4.Department of Neurology, Dell Medical School, The University of Texas at Austin, USA, 5.George Washington University, Washington, USA, 6.Nuffield Department of Clinical Neurosciences, University of Oxford, UK, 7.Neuroimmunology and Neuromuscular Diseases Department, Italy, 8.Department of Neurology, Hanamaki General Hospital, Japan, 9.Department of Neurology, University of South Florida Morsani College of Medicine, USA, 10.UCB Pharma, Other country, 11.Department of Neurology, The University College of North Carolina at Chapel Hill, USA, 12.RAISE Study Investigators, Other country)
Session information
Japanese Poster Session
[Pj-016] Japanese Poster Session 016
Wed. May 31, 2023 5:20 PM - 6:40 PM Poster (幕張メッセ国際展示場 1F 展示ホール7)
Chair:Murai Hiroyuki (International University of Health and Welfare, Japan)
[Pj-016-2] Effectiveness of ravulizumab for patients with refractory myasthenia gravis in our center
Genya Watanabe1, Moeko Arai2, Aki Yasaka3, Mizuki Otomo1, Takafumi Kubota1, Kenichi Tsukita1, Yasushi Suzuki1 (1.National Hospital Organization Sendai Medical Center, Japan, 2.Tome Citizen Hospital, Japan, 3.Public Katta general hospital, Japan)
Yukihiro Hamada1, Masaki Yamana1, Toru Michiura2, Syuichi Ueno1 (1.Neurology of Izumi-city General Hospital, Japan, 2.Department of Neurology, School of Medicine, Kindai University, Japan)
Hisashi Narai, Yoshio Omote, Motonori Takamiya, Yasuhiro Manabe (Department of Neurology, Okayama medical center, Japan)
Kazuki Yoshizumi1, Shohei Watanabe1, Takashi Kimura1, Tomoya Kubota2, Akiyuki Uzawa3, Naoki Kawaguchi3, Masayuki Masuda4, Shingo Konno5, Naoya Minami6, Makoto Samukawa7, Genya Watanabe8, Yasushi Suzuki8, Yuriko Nagane10, Masanori Takahashi2, Shigeaki Suzuki9, Kimiaki Utsugisawa10 (1.Department of Neurology, Hyogo Medical University, Japan, 2.Department of Clinical Laboratory and Biomedical Science, Osaka University, Japan, 3.Department of Neurology, Chiba University, Japan, 4.Department of Neurology, Tokyo Medical University, Japan, 5.Department of Neurology, Toho University Medical Center Oh-Hashi Hospital, Japan, 6.Department of Neurology, Hokkaido Medical Center, Japan, 7.Department of Neurology, Faculty of Medicine, Kindai University, Japan, 8.Department of Neurology, Sendai Medical Center,, Japan, 9.Department of Neurology, Keio University School of Medicine, Japan, 10.Department of Neurology, Hanamaki General Hospital, Japan)
Akiko Ishii, Shogo Ouchi, Tetsu Suzuki, Izummi Mihashi, Hana Takahashi, Kouta Igari, Myuko Tanaka, Hiroshi Tsuji, Kiyotaka Nakamagoe, Yasushi Tomidokoro, Kazuhiro Ishii (Depatment of Neurology, University of Tsukuba, Japan)